Published on 24/12/2025
How to Review Site Infrastructure and Equipment During Clinical Trial Feasibility
Site infrastructure and equipment play a pivotal role in the feasibility and operational success of a clinical trial. Even the most qualified investigators cannot compensate for inadequacies in physical infrastructure, diagnostic tools, or investigational product (IP) storage conditions. This guide provides a structured approach to reviewing site infrastructure and equipment during the feasibility phase to ensure regulatory compliance and protocol readiness.
Why Infrastructure and Equipment Assessment Matters
A site’s ability to manage study procedures, patient safety, and data integrity depends heavily on its infrastructure. Failure to verify the presence and functionality of essential equipment during feasibility can result in:
- Protocol deviations
- Delayed subject enrollment or visit execution
- Compromised sample quality
- Regulatory findings during inspections
Key Areas to Assess During Feasibility
1. Investigational Product (IP) Storage
- Secure, access-controlled storage areas
- Refrigerators and freezers with temperature monitoring and alarm systems
- Backup power systems in case of outages
- Separate storage for controlled substances
2. Clinical Laboratory Capabilities
- On-site sample processing capabilities (centrifuge, dry ice, etc.)
- Availability of a certified lab or partnership with external accredited labs
- Sample storage (frozen, ambient, refrigerated) with labeling compliance
- Logistics support for sample shipment per StabilityStudies.in standards
3. Diagnostic and Imaging Facilities
- Access to equipment required by protocol (e.g., ECG, X-ray, MRI, spirometer)
- Maintenance and calibration logs
4. Clinical Space and Accessibility
- Private examination rooms for subject visits
- Waiting area and consultation space
- Easy accessibility for patients with disabilities
- Dedicated room for monitoring visits (CRA workspace)
5. Data Entry and Technology Infrastructure
- Reliable internet connectivity for EDC systems
- Computers or tablets for eCRF entry
- Access to printers and document scanning tools
- Secure data backup and user access control measures
Feasibility Questionnaire Inclusions
Ensure your feasibility form includes questions on:
- Availability of each piece of equipment listed in the protocol
- Make, model, and last calibration date
- Contingency plans for equipment failure
- Site SOPs for equipment maintenance
- Ability to store and ship biospecimens
Site Tour and Visual Inspection (Virtual or On-site)
Whether conducted virtually or in-person, a site tour offers critical insight:
- Verify storage areas match questionnaire responses
- Photographic or video evidence of equipment setup
- Check expiry dates on IP supplies and calibration certificates
- Evaluate workflow and subject flow through clinical space
Using an Equipment and Infrastructure Checklist
Create a standardized checklist aligned with protocol needs, covering:
- Refrigerated storage (2°C to 8°C)
- Freezer storage (−20°C or −70°C if required)
- Blood pressure monitor, weighing scale, thermometer, etc.
- ECG machine and defibrillator (for certain studies)
- Emergency equipment and SOPs for medical incidents
Templates from Pharma SOPs can support documentation and standardization.
Red Flags to Watch For
- Shared IP storage without restricted access
- No documentation for equipment calibration
- Over-reliance on external labs without proper agreements
- Lack of training records for diagnostic tools
- Improper waste disposal or sample handling SOPs
Integration into Site Scoring and Selection
Assign scores to each infrastructure component using a weighted matrix:
- IP storage readiness (30%)
- Lab and diagnostic capability (25%)
- Data infrastructure (20%)
- Clinical space and accessibility (15%)
- Contingency systems and SOP adherence (10%)
This score feeds into the final site selection decision along with investigator experience and patient pool potential.
Regulatory Guidance
ICH-GCP E6(R2) requires that trial sites be “adequately equipped” to conduct the protocol and handle trial-related emergencies. Agencies like the USFDA and CDSCO expect documentation of infrastructure assessment to be maintained in the Trial Master File (TMF).
Conclusion
Site infrastructure and equipment evaluation is a non-negotiable element of feasibility assessments. A well-documented, checklist-driven review ensures site readiness, regulatory compliance, and study success. Whether evaluating storage conditions or lab capabilities, attention to operational details prevents future deviations and supports high-quality clinical data.